Menu
Currency
GWAS Study

A genome-wide association analysis of temozolomide response using lymphoblastoid cell lines shows a clinically relevant association with MGMT.

Brown CC, Havener TM, Medina MW et al.

23047291 PubMed ID
GWAS Study Type
516 Participants
76 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

BC
Brown CC
HT
Havener TM
MM
Medina MW
AJ
Auman JT
ML
Mangravite LM
KR
Krauss RM
MH
McLeod HL
MA
Motsinger-Reif AA
Chapter II

Abstract

Summary of the research findings

Objective: Recently, lymphoblastoid cell lines (LCLs) have emerged as an innovative model system for mapping gene variants that predict the dose response to chemotherapy drugs.

516 European ancestry lymphoblastoid cell lines

Chapter III

Study Statistics

Key metrics and study information

516
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.